Bevacizumab for Glioblastoma—A Promising Drug or Not?

Author： Nagane Motoo   Nishikawa Ryo  

Publisher： MDPI

E-ISSN： 2072-6694|5|4|1456-1468

ISSN： 2072-6694

Source： Cancers, Vol.5, Iss.4, 2013-11, pp. : 1456-1468

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Three-Times Daily Ultrafractionated Radiation Therapy, A Novel and Promising Regimen for Glioblastoma Patients

By Beauchesne Patrick  

Cancers, Vol. 5, Iss. 4, 2013-09 ,pp. : 1199-1211

MDPI

Access to resources Recommend Favorite

Strategies in Gene Therapy for Glioblastoma

By Kwiatkowska Aneta   Nandhu Mohan S.   Behera Prajna   Chiocca E. Antonio   Viapiano Mariano S.  

Cancers, Vol. 5, Iss. 4, 2013-10 ,pp. : 1271-1305

MDPI

Access to resources Recommend Favorite

Emerging Biomarkers in Glioblastoma

By McNamara Mairéad G.   Sahebjam Solmaz   Mason Warren P.  

Cancers, Vol. 5, Iss. 3, 2013-08 ,pp. : 1103-1119

MDPI

Access to resources Recommend Favorite

Is Glioblastoma an Epigenetic Malignancy?

By Maleszewska Marta   Kaminska Bozena  

Cancers, Vol. 5, Iss. 3, 2013-09 ,pp. : 1120-1139

MDPI

Access to resources Recommend Favorite

Advance Care Planning in Glioblastoma Patients

By Fritz Lara   Dirven Linda   Reijneveld Jaap C.   Koekkoek Johan A. F.   Stiggelbout Anne M.   Pasman H. Roeline W.   Taphoorn Martin J. B.  

Cancers, Vol. 8, Iss. 11, 2016-11 ,pp. : 102-102

MDPI

Access to resources Recommend Favorite